Ovagen

Ovagen is a synthetic Khavinson peptide bioregulator marketed for liver and gastrointestinal support, and users typically take it off‑label to try to boost liver function, aid digestion, or reduce gut inflammation. The prevailing community regimen mirrors a clinician‑tier guideline of 200 µg taken orally each day; timing and cycling are left to individual preference. The single practical drawback is that Ovagen lacks any FDA‑approved indication, meaning all human use is off‑label and must be compounded, with no clinical trials currently reported.

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsno dataPrice0.43.02.0

Measured on 3 of 6 axes

Research Evidence

Evidence shape

Ovagen currently exists as an animal-only research compound with no published human clinical trials. The existing literature is restricted to preclinical and mechanistic studies, providing no data on safety or efficacy in human subjects. Because there are no registered trials or completed human studies, the clinical profile remains entirely unmapped.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth4 rows captured
Human
direct clinical signal
0
Animal
translational support
1
In vitro
mechanistic support
3
HighMediumLow

Anecdotal efficacy

Ovagen side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Symptom-relevant clinical or community evidence has not been captured for this peptide yet.

1
unknown
20 mg
$39.99
$2/mg
2
GB
20 mg
$40.27
$2.01/mg
3
--
20 mg
$48.00
$2.4/mg
4
US
20 mg
$48.00
$2.4/mg
5
--
20 mg
$49.00
$2.45/mg
6
unknown
20 mg
$49.99
$2.5/mg

price offers can be sorted by column

1-6 of 24

Ovagen dosing & protocol

How Ovagen is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
0
10 mg
20 mg
30 mg
40 mg
50 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance · n = 1
Typical dose
200 µg
typical
0
10 mg
20 mg
30 mg
40 mg
50 mg
across 1 dosed source · darker = more agree
By reported cadence
Daily200 µg · n=1
Frequency
daily
Route
oral

Based on a single source, the clinician practice tier lists 200 mcg of Ovagen taken orally each day, with no specified cycle or weight‑based adjustment.

1 source
Anecdotal
Community-reported real-world use · n = 1
Typical dose
25 mg25 mg – 50 mg
typical
0
10 mg
20 mg
30 mg
40 mg
50 mg
distribution of 2 reported doses · darker = more
Frequency
unspecified

Anecdotal reports cite a typical dose of 25 mg, with a range of 25–50 mg per pill; no consistent frequency or cycling pattern is documented.

1 source